Murphy Middleton Hinkle & Parker’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Hold
5,310
0.17% 106
2026
Q1
$460K Sell
5,310
-6,653
-56% -$637K 0.21% 96
2025
Q4
$213K Buy
11,963
+6,653
+125% +$646K 0.1% 126
2025
Q3
$506K Hold
5,310
0.25% 93
2025
Q2
$477K Hold
5,310
0.27% 92
2025
Q1
$477K Hold
5,310
0.27% 92
2024
Q4
$424K Sell
5,310
-400
-7% -$34.6K 0.24% 97
2024
Q3
$514K Buy
5,710
+400
+8% +$33.6K 0.28% 91
2024
Q2
$418K Sell
5,310
-100
-2% -$8.2K 0.24% 97
2024
Q1
$471K Sell
5,410
-412
-7% -$35.2K 0.27% 93
2023
Q4
$480K Sell
5,822
-1,204
-17% -$91.8K 0.3% 86
2023
Q3
$551K Buy
7,026
+400
+6% +$33.5K 0.35% 79
2023
Q2
$584K Sell
6,626
-400
-6% -$34.4K 0.36% 80
2023
Q1
$566K Sell
7,026
-100
-1% -$8.15K 0.35% 81
2022
Q4
$554K Buy
7,126
+30
+0.4% +$2.43K 0.35% 84
2022
Q3
$573K Sell
7,096
-95
-1% -$8.54K 0.4% 78
2022
Q2
$645K Hold
7,191
0.42% 77
2022
Q1
$798K Hold
7,191
0.43% 76
2021
Q4
$744K Hold
7,191
0.4% 76
2021
Q3
$901K Sell
7,191
-265
-4% -$34.3K 0.52% 60
2021
Q2
$926K Hold
7,456
0.52% 62
2021
Q1
$881K Sell
7,456
-40
-0.5% -$4.69K 0.51% 61
2020
Q4
$878K Sell
7,496
-228
-3% -$25.1K 0.58% 56
2020
Q3
$803K Hold
7,724
0.59% 54
2020
Q2
$708K Hold
7,724
0.52% 58
2020
Q1
$697K Hold
7,724
0.62% 52
2019
Q4
$876K Hold
7,724
0.58% 58
2019
Q3
$839K Buy
7,724
+1
+0% +$104 0.59% 57
2019
Q2
$752K Sell
7,723
-500
-6% -$45.7K 0.54% 62
2019
Q1
$749K Hold
8,223
0.51% 63
2018
Q4
$748K Sell
8,223
-540
-6% -$50.5K 0.57% 55
2018
Q3
$862K Hold
8,763
0.61% 57
2018
Q2
$750K Hold
8,763
0.56% 59
2018
Q1
$703K Sell
8,763
-1
-0% -$82 0.55% 60
2017
Q4
$708K Buy
+8,764
New +$702K 0.53% 59

Other funds holding MDT

Murphy Middleton Hinkle & Parker's MDT Position: Q2 2026 in Review

Murphy Middleton Hinkle & Parker held its Medtronic (MDT) position steady in Q2 2026 at 5,310 shares worth $415K. The position accounts for 0.17% of the portfolio, ranked #106.

Murphy Middleton Hinkle & Parker first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $926K in Q2 2021. 428 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Murphy Middleton Hinkle & Parker held 5,310 shares of Medtronic worth $415K as of Q2 2026.
  • Murphy Middleton Hinkle & Parker left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.17% of Murphy Middleton Hinkle & Parker's portfolio in Q2 2026, its #106 holding.
  • Murphy Middleton Hinkle & Parker first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
  • Murphy Middleton Hinkle & Parker's Medtronic position peaked at $926K in Q2 2021.
  • 428 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Murphy Middleton Hinkle & Parker's 13F filing for Q2 2026, filed 14 Jul 2026.